213 related articles for article (PubMed ID: 19057529)
1. beta-Cell function and insulin sensitivity in adolescents from an OGTT.
Sunehag AL; Man CD; Toffolo G; Haymond MW; Bier DM; Cobelli C
Obesity (Silver Spring); 2009 Feb; 17(2):233-9. PubMed ID: 19057529
[TBL] [Abstract][Full Text] [Related]
2. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
Xu L; Man CD; Charbonnel B; Meninger G; Davies MJ; Williams-Herman D; Cobelli C; Stein PP
Diabetes Obes Metab; 2008 Dec; 10(12):1212-20. PubMed ID: 18476982
[TBL] [Abstract][Full Text] [Related]
3. Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study.
Campioni M; Toffolo G; Shuster LT; Service FJ; Rizza RA; Cobelli C
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E54-60. PubMed ID: 16868229
[TBL] [Abstract][Full Text] [Related]
4. Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals.
Dalla Man C; Campioni M; Polonsky KS; Basu R; Rizza RA; Toffolo G; Cobelli C
Diabetes; 2005 Nov; 54(11):3265-73. PubMed ID: 16249454
[TBL] [Abstract][Full Text] [Related]
5. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
[TBL] [Abstract][Full Text] [Related]
6. Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort.
Rijkelijkhuizen JM; Girman CJ; Mari A; Alssema M; Rhodes T; Nijpels G; Kostense PJ; Stein PP; Eekhoff EM; Heine RJ; Dekker JM
Diabetes Res Clin Pract; 2009 Feb; 83(2):280-8. PubMed ID: 19097663
[TBL] [Abstract][Full Text] [Related]
7. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests.
Cobelli C; Toffolo GM; Dalla Man C; Campioni M; Denti P; Caumo A; Butler P; Rizza R
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E1-E15. PubMed ID: 17341552
[TBL] [Abstract][Full Text] [Related]
8. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
Muscelli E; Mari A; Natali A; Astiarraga BD; Camastra S; Frascerra S; Holst JJ; Ferrannini E
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1144-50. PubMed ID: 16478775
[TBL] [Abstract][Full Text] [Related]
9. Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome.
Ehrmann DA; Breda E; Corcoran MC; Cavaghan MK; Imperial J; Toffolo G; Cobelli C; Polonsky KS
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E241-6. PubMed ID: 14665448
[TBL] [Abstract][Full Text] [Related]
10. The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.
Hansen T; Drivsholm T; Urhammer SA; Palacios RT; Vølund A; Borch-Johnsen K; Pedersen O
Diabetes Care; 2007 Feb; 30(2):257-62. PubMed ID: 17259491
[TBL] [Abstract][Full Text] [Related]
11. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
Li X; Zhou ZG; Qi HY; Chen XY; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
[TBL] [Abstract][Full Text] [Related]
12. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.
Dalla Man C; Caumo A; Basu R; Rizza R; Toffolo G; Cobelli C
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E637-43. PubMed ID: 15138152
[TBL] [Abstract][Full Text] [Related]
13. Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT.
Tura A; Kautzky-Willer A; Pacini G
Diabetes Res Clin Pract; 2006 Jun; 72(3):298-301. PubMed ID: 16325298
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
15. Assessment of hepatic insulin degradation, in normoglycemic hypertensive patients, by minimal modelling of standard intravenous glucose tolerance test data.
Di Nardo F; Boemi M; Burattini R
Comput Methods Programs Biomed; 2010 Feb; 97(2):189-98. PubMed ID: 19767120
[TBL] [Abstract][Full Text] [Related]
16. Impaired beta-cell function in lean normotolerant former gestational diabetic women.
Tura A; Mari A; Winzer C; Kautzky-Willer A; Pacini G
Eur J Clin Invest; 2006 Jan; 36(1):22-8. PubMed ID: 16403006
[TBL] [Abstract][Full Text] [Related]
17. Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model.
Dalla Man C; Caumo A; Basu R; Rizza R; Toffolo G; Cobelli C
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E909-14. PubMed ID: 15972269
[TBL] [Abstract][Full Text] [Related]
18. Effect of naltrexone treatment on insulin secretion, insulin action and postprandial thermogenesis in obesity.
Vettor R; Macor C; Rossi E; De Palo C; Ruggeri A; Cobelli C; Federspil G
Horm Metab Res; 1994 Apr; 26(4):188-94. PubMed ID: 8082873
[TBL] [Abstract][Full Text] [Related]
19. The oral glucose minimal model: estimation of insulin sensitivity from a meal test.
Dalla Man C; Caumo A; Cobelli C
IEEE Trans Biomed Eng; 2002 May; 49(5):419-29. PubMed ID: 12002173
[TBL] [Abstract][Full Text] [Related]
20. Estimation of beta-cell function from the data of the oral glucose tolerance test.
Sakaue S; Ishimaru S; Ikeda D; Ohtsuka Y; Honda T; Suzuki J; Kawakami Y; Ishii J; Nishimura M
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1575-80. PubMed ID: 17284580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
